甲状腺乳头状癌患者血清样本代谢组学分析
Metabolomics Analysis of Serum Samples from Patients with Papillary Thyroid Cancer
DOI: 10.12677/ACM.2023.13112415, PDF,   
作者: 赵 阳:青岛大学医学部,山东 青岛;赵 明, 王 睿:青岛大学附属青岛市中心医院甲状腺外科,山东 青岛;张方华*:青岛大学附属青岛市中心医院内分泌与代谢性疾病科,山东 青岛
关键词: 甲状腺乳头状癌代谢组学代谢通路生物标志物Thyroid Papillary Carcinoma Metabolomics Metabolic Pathways Biomarkers
摘要: 目的:分析对比甲状腺乳头状癌(PTC)及健康成人血清样本筛选差异代谢物和异常代谢通路,为PTC的早 期诊疗提供新的思路。方法:选取2022年3月至2022年12月就诊于山东省青岛大学附属中心医院经病理 确诊的PTC患者的血清样本30例,并收集健康成人血清样本36例,利用超高效液相色谱四极杆飞行时间 质谱联用技术,采用主成分分析和偏最小二乘判别分析等方法进行数据处理,筛选差异相关的生物标志 物和代谢通路。结果:通过分析筛选获得41种可信差异代谢物,其中22种下调,19种上调,在PTC中, α-溶血磷脂酸、花生四烯酸等呈下降趋势;顺乌头酸、α-亚麻酸等呈上升趋势。筛选出20条代谢通路, 分别为氮代谢、赖氨酸降解通路、花生四烯酸代谢通路等。结论:PTC和健康成人组代谢轮廓存在显著 差异;糖酵解、氨基酸代谢、脂代谢参与了PTC的病理过程。
Abstract: Objective: To analyze and compare the differential metabolites and abnormal metabolic pathways in serum samples of papillary thyroid carcinoma (PTC) and healthy adults, and provide new ideas for the early diagnosis and treatment of PTC. Method: Thirty serum samples of PTC patients diagnosed with pathology at the Affiliated Central Hospital of Qingdao University in Shandong Province from March 2022 to December 2022 were selected, and 36 healthy adult serum samples were collected. The data were processed using ultra-high performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC), principal component analysis (PCA), partial least squares discriminant analysis (PLSA), and differentially correlated biomarkers and metabolic pathways were screened. Result: 41 credible differential metabolites were obtained through analysis and screening, of which 22 were down regulated and 19 were up regulated. In PTC, α-Lysophosphatidic acid and arachidonic acid showed a downward trend; Shunaconitic acid α-Linolenic acid and other substances are showing an upward trend. 20 metabolic pathways were screened, including nitrogen metabolism, lysine degradation pathway, arachidonic acid metabolism pathway, etc. Conclusion: There is a significant difference in metabolic profile between PTC and healthy adult groups; glycolysis, amino acid metabolism, and lipid metabolism are involved in the pathological process of PTC.
文章引用:赵阳, 赵明, 王睿, 张方华. 甲状腺乳头状癌患者血清样本代谢组学分析[J]. 临床医学进展, 2023, 13(11): 17230-17244. https://doi.org/10.12677/ACM.2023.13112415

参考文献

[1] Haymart, M.R. (2021) Progress and Challenges in Thyroid Cancer Management. Endocrine Practice, 27, 1260-1263. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, D.W., Lang, B.H.H., Mcleod, D.S.A., Newbold, K. and Haymart, M.R. (2023) Thyroid Cancer. The Lancet, 401, 1531-1544. [Google Scholar] [CrossRef
[3] Haugen, B.R., Alexander, E.K., Bible, K.C., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thy-roid Cancer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]
[4] Pizzato, M., Li, M., Vignat, J., et al. (2022) The Epidemiological Land-scape of Thyroid Cancer Worldwide: GLOBOCAN Estimates for Incidence and Mortality Rates in 2020. The Lancet Diabetes and Endocrinology, 10, 264-272. [Google Scholar] [CrossRef
[5] Bauermeister, A., Mannochio-Russo, H., Costa-Lotufo, L.V., Jarmusch, A.K. and Dorrestein, P.C. (2022) Mass Spectrometry-Based Metabolomics in Microbiome Investigations. Nature Reviews Microbiology, 20, 143-160. [Google Scholar] [CrossRef] [PubMed]
[6] Anwardeen, N.R., Diboun, I., Mokrab, Y., Althani, A.A. and Elrayess, M.A. (2023) Statistical Methods and Resources for Biomarker Discovery Using Metabolomics. BMC Bioin-formatics, 24, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
[7] Chacko, S., Haseeb, Y.B. and Haseeb, S. (2022) Metabolomics Work Flow and Analytics in Systems Biology. Current Molecular Medicine, 22, 870-881. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, X. and Yu, D. (2019) Metabolomics Study of Oral Cancers. Metabolomics, 15, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[9] Ganesan, R., Yoon, S.J. and Suk, K.T. (2022) Microbiome and Metabolomics in Liver Cancer: Scientific Technology. International Journal of Molecular Sciences, 24, Article 537. [Google Scholar] [CrossRef] [PubMed]
[10] Xiao, Y., Ma, D., Yang, Y.S., et al. (2022) Comprehensive Metabo-lomics Expands Precision Medicine for Triple-Negative Breast Cancer. Cell Research, 32, 477-490. [Google Scholar] [CrossRef] [PubMed]
[11] Li, M., Dal Maso, L. and Vaccarella, S. (2020) Global Trends in Thyroid Cancer Incidence and the Impact of Overdiagnosis. The Lancet Diabetes and Endocrinology, 8, 468-470. [Google Scholar] [CrossRef
[12] Kodama, M. and Nakayama, K.I. (2020) A Second War-burg-Like Effect in Cancer Metabolism: The Metabolic Shift of Glutamine-Derived Nitrogen: A Shift in Gluta-mine-Derived Nitrogen Metabolism from Glutaminolysis to De Novo Nucleotide Biosynthesis Contributes to Malignant Evolution of Cancer. BioEssays, 42, e2000169. [Google Scholar] [CrossRef] [PubMed]
[13] Arguello, R.J., Combes, A.J., Char, R., et al. (2020) SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. Cell Metabolism, 32, 1063-1075. [Google Scholar] [CrossRef] [PubMed]
[14] Feng, J., Li, J., Wu, L., et al. (2020) Emerging Roles and the Reg-ulation of Aerobic Glycolysis in Hepatocellular Carcinoma. Journal of Experimental & Clinical Cancer Research, 39, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
[15] Cao, L., Wu, J., Qu, X., et al. (2020) Glycometabolic Rear-rangements—Aerobic Glycolysis in Pancreatic Cancer: Causes, Characteristics and Clinical Applications. Journal of Ex-perimental & Clinical Cancer Research, 39, Article No. 267. [Google Scholar] [CrossRef] [PubMed]
[16] Miccoli, P., Torregrossa, L., Shintu, L., et al. (2012) Metabo-lomics Approach to Thyroid Nodules: A High-Resolution Magic-Angle Spinning Nuclear Magnetic Resonance-Based Study. Surgery, 152, 1118-1124. [Google Scholar] [CrossRef] [PubMed]
[17] Bian, X., Liu, R., Meng, Y., et al. (2021) Lipid Metabolism and Cancer. Journal of Experimental Medicine, 218, e20201606. [Google Scholar] [CrossRef] [PubMed]
[18] Li, D. and Li, Y. (2020) The Interaction between Ferroptosis and Lipid Metabolism in Cancer. Signal Transduction and Targeted Therapy, 5, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[19] Arslanbaeva, L., Tosi, G., Ravazzolo, M., et al. (2022) UBIAD1 and CoQ10 Protect Melanoma Cells from Lipid Peroxidation-Mediated Cell Death. Redox Biology, 51, Article ID: 102272. [Google Scholar] [CrossRef] [PubMed]
[20] Lin, F., Li, X., Wang, X., et al. (2022) Stanniocalcin 1 Promotes Metastasis, Lipid Metabolism and Cisplatin Chemoresistance via the FOXC2/ITGB6 Signaling Axis in Ovarian Cancer. Journal of Experimental & Clinical Cancer Research, 41, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[21] Ippolito, L., Comito, G., Parri, M., et al. (2022) Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer. Cancer Research, 82, 1267-1282. [Google Scholar] [CrossRef
[22] Zhu, Y., Gu, L., Lin, X., et al. (2020) Dynamic Regulation of ME1 Phosphorylation and Acetylation Affects Lipid Metabolism and Colorectal Tumorigenesis. Molecular Cell, 77, 138-149. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, H., Yi, J.K., Huang, H., et al. (2021) Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway in vitro and in vivo. Cancers, 13, Article 2176. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, S., Fu, J.L., Hao, H.F., et al. (2021) Metabolic Repro-gramming by Traditional Chinese Medicine and Its Role in Effective Cancer Therapy. Pharmacological Research, 170, Article ID: 105728. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, H., Ma, L., Kim, E., et al. (2023) Rhein Induces Oral Can-cer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway in vitro and in vivo. International Journal of Molecular Sciences, 24, Article 8507. [Google Scholar] [CrossRef] [PubMed]
[26] Gupta, S., Sahu, D., Bomalaski, J.S., et al. (2018) Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocrine Pathology, 29, 236-241. [Google Scholar] [CrossRef] [PubMed]
[27] Matos, A., Carvalho, M., Bicho, M. and Ribeiro, R. (2021) Argi-nine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression. Nutrients, 13, Article 4503. [Google Scholar] [CrossRef] [PubMed]
[28] Yuan, J.B., Gu, L., Chen, L., Yin, Y. And Fan, B.Y. (2021) Annexin A8 Regulated by lncRNA-TUG1/miR-140-3p Axis Promotes Bladder Cancer Progression and Metastasis. Mo-lecular Therapy-Oncolytics, 22, 36-51. [Google Scholar] [CrossRef] [PubMed]
[29] Johnson, C.H., Dejea, C.M., Edler, D., et al. (2015) Metabolism Links Bacterial Biofilms and Colon Carcinogenesis. Cell Metabolism, 21, 891-897. [Google Scholar] [CrossRef] [PubMed]
[30] Wikoff, W.R., Hanash, S., Defelice, B., et al. (2015) Diacetyl-spermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance with Pro-Surfactant Protein B. Journal of Clinical Oncology, 33, 3880-3886. [Google Scholar] [CrossRef
[31] Umemori, Y., Ohe, Y., Kuribayashi, K., et al. (2010) Evaluating the Utility of N1, N12-Diacetylspermine and N1, N8-Diacetylspermidine in Urine as Tumor Markers for Breast and Col-orectal Cancers. Clinica Chimica Acta, 411, 1894-1899. [Google Scholar] [CrossRef] [PubMed]
[32] Zhu, Y., Piao, C., Zhang, Z., et al. (2022) The Potential Role of c-MYC and Polyamine Metabolism in Multiple Drug Resistance in Bladder Cancer Investigated by Metabonomics. Genomics, 114, 125-137.
[33] Geng, P., Qin, W. and Xu, G. (2021) Proline Metabolism in Cancer. Amino Acids, 53, 1769-1777. [Google Scholar] [CrossRef] [PubMed]